2025-03-13 04:42:23
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Lasa Supergenerics Q3FY22 loss at Rs. 4.71 crores
Posted On : 2022-02-07 18:41:54( TIMEZONE : IST )
Lasa Supergenerics Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 15.7504 crores during the period ended December 31, 2021 as compared to Rs. 34.1316 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -4.7141 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -13.7434 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -1.16 for the period ended December 31, 2021 as compared to Rs. -3.38 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹15.7504 crs | ₹34.1316 crs |  -53.85% |
| Net Profit | ₹-4.7141 crs | ₹-13.7434 crs |  65.70% |
| EPS | ₹-1.16 | ₹-3.38 | 65.68% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs.15.7504 crores during the period ended December 31, 2021 as compared to Rs.54.0021 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-4.7141 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.6.5556 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-1.16 for the period ended December 31, 2021 as compared to Rs.1.61 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹15.7504 crs | ₹54.0021 crs | -70.83% |
| Net Profit | ₹-4.7141 crs | ₹6.5556 crs | -171.91% |
| EPS | ₹-1.16 | ₹1.61 | -172.05% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.85.9625 crores during the 9 Months period ended December 31, 2021 as compared to Rs.163.3304 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-17.6515 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.18.9798 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-3.18 for the 9 Months period ended December 31, 2021 as compared to Rs.4.67 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹85.9625 crs | ₹163.3304 crs | -47.37% |
| Net Profit | ₹-17.6515 crs | ₹18.9798 crs | -193.00% |
| EPS | ₹-3.18 | ₹4.67 | -168.09% |
Shares of Lasa Supergenerics Limited was last trading in BSE at Rs. 64.00 as compared to the previous close of Rs. 64.35. The total number of shares traded during the day was 38140 in over 659 trades.
The stock hit an intraday high of Rs. 65.25 and intraday low of 63.20. The net turnover during the day was Rs. 2463639.00.
